Last reviewed · How we verify

NCT03069560: C-SIAM

Short Message System (SMS) for Caregivers of Suicidal Patients to Prevent Recidivism of Suicide Attempts

Completed NA Last updated 3 December 2025
What this trial tests

NA trial testing SMS in Prevention of the Suicide in 15 participants. Completed in 8 August 2019.

Timeline
19 July 2017
Primary endpoint
8 August 2019
8 August 2019

Quick facts

Lead sponsorUniversity Hospital, Brest
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment15
Start date19 July 2017
Primary completion8 August 2019
Estimated completion8 August 2019
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Brest

Who can join

18 and older, any sex, with Prevention of the Suicide. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assessment of the feasibility of a monitoring device by SMS in which messages are sent by the caregiver after a suicidal act.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of SMS

Trials testing the same drug.

Other University Hospital, Brest trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03069560.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing